PERI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 36.195
EU - Europa 21.311
AS - Asia 10.972
SA - Sud America 1.531
AF - Africa 273
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 20
Totale 70.341
Nazione #
US - Stati Uniti d'America 35.192
DE - Germania 5.624
SE - Svezia 4.597
SG - Singapore 3.358
IT - Italia 3.275
DK - Danimarca 2.820
CN - Cina 2.523
VN - Vietnam 1.813
HK - Hong Kong 1.306
RU - Federazione Russa 1.205
BR - Brasile 1.191
CA - Canada 839
IE - Irlanda 630
GB - Regno Unito 547
FR - Francia 536
UA - Ucraina 534
PL - Polonia 412
IN - India 405
BD - Bangladesh 292
FI - Finlandia 244
AT - Austria 237
NL - Olanda 209
KR - Corea 201
ID - Indonesia 159
TR - Turchia 142
JP - Giappone 126
IQ - Iraq 123
ES - Italia 120
AR - Argentina 102
BE - Belgio 98
PK - Pakistan 95
MX - Messico 93
ZA - Sudafrica 88
EC - Ecuador 55
SA - Arabia Saudita 55
PH - Filippine 48
CO - Colombia 47
UZ - Uzbekistan 42
CH - Svizzera 40
VE - Venezuela 40
CL - Cile 37
RO - Romania 36
MY - Malesia 33
MA - Marocco 31
AU - Australia 30
LT - Lituania 29
EG - Egitto 28
IR - Iran 27
TW - Taiwan 26
KE - Kenya 24
AE - Emirati Arabi Uniti 23
PY - Paraguay 23
ET - Etiopia 22
JO - Giordania 22
NP - Nepal 22
TN - Tunisia 21
IL - Israele 19
DZ - Algeria 18
AZ - Azerbaigian 17
PT - Portogallo 16
CZ - Repubblica Ceca 15
GR - Grecia 15
PE - Perù 13
TH - Thailandia 13
EU - Europa 12
LB - Libano 12
CR - Costa Rica 10
DO - Repubblica Dominicana 10
JM - Giamaica 10
UY - Uruguay 10
AL - Albania 9
BO - Bolivia 9
HU - Ungheria 8
KZ - Kazakistan 8
LV - Lettonia 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
OM - Oman 8
PS - Palestinian Territory 8
BB - Barbados 7
BG - Bulgaria 7
KG - Kirghizistan 7
PA - Panama 7
RS - Serbia 7
TT - Trinidad e Tobago 7
MU - Mauritius 6
SY - Repubblica araba siriana 6
HN - Honduras 5
MD - Moldavia 5
NG - Nigeria 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
AO - Angola 4
BY - Bielorussia 4
GE - Georgia 4
GY - Guiana 4
NI - Nicaragua 4
SC - Seychelles 4
SN - Senegal 4
BH - Bahrain 3
Totale 70.269
Città #
Ann Arbor 19.992
Frankfurt am Main 5.173
Stockholm 3.750
Singapore 1.889
Ashburn 1.624
Hong Kong 1.252
Woodbridge 1.151
Wilmington 1.093
Milan 1.046
San Jose 1.013
Chandler 942
Fairfield 884
Houston 620
Dublin 603
Toronto 543
Jacksonville 507
Ho Chi Minh City 494
Seattle 373
Hanoi 367
Santa Clara 351
Beijing 350
Rome 339
Kraków 329
Los Angeles 313
Dearborn 311
New York 293
Chicago 274
Hefei 270
Cambridge 268
Princeton 232
Council Bluffs 230
Dong Ket 220
Vienna 210
Nanjing 191
Boardman 189
Seoul 181
The Dalles 180
Dallas 172
Shanghai 154
São Paulo 138
Altamura 131
Guangzhou 131
Lauterbourg 121
Buffalo 120
Jakarta 120
Lawrence 107
Helsinki 103
Tokyo 91
Brussels 85
San Diego 83
Lachine 80
Moscow 80
Orem 75
Florence 65
Munich 61
London 58
Chennai 56
Da Nang 55
Amsterdam 54
Warsaw 54
Montreal 53
Columbus 50
Ottawa 50
Turin 50
Brooklyn 48
Hangzhou 48
Washington 48
Fremont 47
Johannesburg 47
Hyderabad 46
Jinan 46
Baghdad 45
Haiphong 45
Tianjin 45
Denver 42
Falls Church 42
Phoenix 42
Nuremberg 40
Montréal 39
Shenyang 39
Tashkent 39
Atlanta 38
Hebei 38
Nanchang 37
Rio de Janeiro 37
Andover 36
Changsha 36
Dhaka 36
Paris 35
Bologna 34
Boston 33
Brescia 32
Brasília 31
Piscataway 31
Biên Hòa 29
Huizen 29
Kent 29
Manchester 29
San Francisco 29
Newark 28
Totale 51.819
Nome #
Representative secondary PET micro and nanoplastics via ethylene glycol fragmentation (EGF): Physicochemical and immuno-toxicological properties 1.955
Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives 1.928
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties 832
Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model 810
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists 807
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation 795
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 753
Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)-and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling 746
Structural characterization of aerogels derived from enzymatically oxidized galactomannans of fenugreek, sesbania and guar gums 736
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection 710
Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives 696
A new advanced cellular model of functional cholinergic-like neurons developed by reprogramming the human SH-SY5Y neuroblastoma cell line 688
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 685
First experimental identification of Ras-inhibitor binding interface using a water-soluble Ras ligand 682
Dye-sensitized photocatalytic hydrogen production: Distinct activity in a glucose derivative of a phenothiazine dye 679
The Role of TLR4 in Neural Stem Cells–Mediated Neurogenesis and Neuroinflammation 678
Functional characterization of E. coli LptC: Interaction with LPS and a synthetic ligand 677
Co-administration of Antimicrobial Peptides Enhances Toll-like Receptor 4 Antagonist Activity of a Synthetic Glycolipid 666
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 659
The role of carbohydrates in the lipopolysaccharide (LPS)/toll-like receptor 4 (TLR4) Signalling 649
Synthesis of the New Cyanine-Labeled Bacterial Lipooligosaccharides for Intracellular Imaging and in Vitro Microscopy Studies 646
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition 641
Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic 633
Dye-Sensitized Photocatalytic Hydrogen Generation: Efficiency Enhancement by Organic Photosensitizer-Coadsorbent Intermolecular Interaction 632
Binding properties and biological characterization of new sugar-derived Ras ligands 630
Glycolipids and benzylammonium lipids as novel antisepsis agents: Synthesis and biological characterization 623
Glycolipid-based TLR4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological Properties 617
Structure and inflammatory activity of the LPS isolated from Acetobacter pasteurianus CIP103108 617
Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling 610
Exploring the LPS/TLR4 signal pathway with small molecules 609
Trehalose- and glucose-derived glycoamphiphiles: Small-molecule and nanoparticle toll-like receptor 4 (TLR4) modulators 601
Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice 600
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 600
Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity 600
Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update 597
A Synthetic Lipid A Mimetic Modulates Human TLR4 Activity 585
TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis 585
Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis 583
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists 582
Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets 580
Synthesis and biological evaluation of novel lipid A antagonists 575
The cationic amphiphile 3,4-bis (tetradecyloxy) benzylamine inhibits LPS signaling by competing with endotoxin for CD14 binding 565
A new isoluminol reagent for chemiluminescence labeling of proteins 559
Synthetic molecules and functionalized nanoparticles targeting the LPS-TLR4 signaling: a new generation of immunotherapeutics 558
How do viruses interfere with Toll-like receptor 4? 554
Inhibition of lipid A stimulated activation of human dendritic cells and macrophages by amino and hydroxylamino monosaccharides 539
Evidence of a specific interaction between new synthetic antisepsis agents and CD14 539
Sugar-derived Ras inhibitors: Group epitope mapping by NMR spectroscopy and biological evaluation 536
Modulation of LPS signaling through TLR4 agonists and antagonists 534
Design and characterisation of a new class of inhibitors of Ras activation 533
The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling 533
Design, Synthesis and Biological Evaluation of Levoglucosenone-derived Ras Activation Inhibitors 521
Multivalent glycoconjugates as anti-pathogenic agents 520
Rigid polycycles and peptidomimetics from carbohydrate synthons 517
Compound for the covalent attachment of the chemiluminescent probe N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) to target molecules and uses thereof 517
Clustered carbohydrates in synthetic vaccines 514
Optimizing operating conditions and electrochemical characterization of glucose-gluconate alkaline fuel cells 510
Carbohydrate-based bioactive compounds for medicinal chemistry applications 508
Design, synthesis and biological evaluation of sugar-derived Ras inhibitors 506
Editorial 504
NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR 495
Glycoconjugates in cancer therapy 492
Arabinose-derived Bicyclic Amino Acids: Synthesis, Conformational Analysis and Construction of an avb3-selective RGD Peptide 492
Chemoselective neoglycosylation 490
Carbohydrate Scaffolds for the Production of Bioactive Compounds 490
Novel α-conotoxin from Conus spurius and the α-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcoline receptors 488
Chemistry of lipid a: At the heart of innate immunity 487
A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development 478
Clicked and long spaced galactosyl- and lactosylcalix[4]arenes: New multivalent galectin-3 ligands 476
Looking forward: A glance into the future of organic chemistry 475
Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope 474
Studies on the mechanism of action of a new class of inhibitors of Ras activation 470
Sugar-derived amino acids: powerful secondary structure inducing elements in the design of novel peptidomimetics 468
Polycyclic Scaffolds from Fructose 465
Solution and solid-phase chemoselective synthesis of (1-6)-amino(methoxy) di- and trisaccharide analogues 465
Chemoselective Ligation in Glycochemistry 465
Glycoconjugate and oligosaccharide mimetics by chemoselective ligation 463
Extending chemoselective ligation to sugar chemistry:convergent assembly of bioactive neoglycoconjugates 463
Synthesis of bicyclic sugar azido acids and their incorporation in cyclic peptides 461
Sugar-Based Inhibitors of Ras Activation: Biological Activity and Identification of Ras–Inhibitor Binding Interface 461
Synthesis of imino sugar scaffolds for the generation of glycosidase inhibitor libraries 458
Molecular simplification of lipid A structure: TLR4-modulating cationic and anionic amphiphiles 458
Assembly of binding loops on aromatic templates as V CAM-1 mimetics 454
Discrimination Properties of Tetraamidic Branched Selectors 453
Synthesis of imino-C-disaccharides related to sucrose 452
Conversion of lactose into mimics of N-acetyllactosamine 447
Carbohydrate-based Scaffolds for the generation of sortiments of bioactive compounds 446
Lipid A antagonists with anti-septic shock, anti-inflammatory, anti-ischemia and analgesic activity 445
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants 445
Chemoselective glycosylation techniques for the synthesis of bioactive neoglycoconjugates, glyconanoparticles and glycoarrays 442
A new procedure for the synthesis of C-glycosides of nojirimycin 441
The EuroSciCon's 2015 Innate Immunity Summit 440
Stepwise synthesis and structural characterization of calix[4]- and calix[5]arenes bearing a functionalized arm on the methylene bridge 438
D-glucose as a regioselectively addressable scaffold for combinatorial chemistry on solid phase 437
Green and Roasted Coffee Extracts Inhibit Interferon-β Release in LPS-Stimulated Human Macrophages 433
Stereoselective synthesis of α-C-glycosides of N-acetylgalactosamine 432
The bone morphogenic protein antagonist Drm/gremlin is a novel pro- angiogenic factor 430
Regioselection and orthogonality of the 1-phenyl-3-butenyl (PBU) protecting group in glucopyranosides 429
Glycidic scaffolds in Peptidomimetic synthesis 428
Tin-mediated regioselective acylation of unprotected sugars on solid phase 424
Totale 57.994
Categoria #
all - tutte 162.790
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 162.790


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211.080 1.142 1.083 967 1.112 887 869 785 847 676 868 787 1.057
2022/20238.296 1.376 1.724 1.100 997 928 1.111 161 295 250 175 104 75
2023/20242.842 84 188 345 160 351 433 448 141 184 86 110 312
2024/20256.194 324 548 455 326 461 300 334 353 588 926 547 1.032
2025/202619.520 1.885 981 1.133 1.638 1.611 788 2.028 676 1.588 5.207 986 999
2026/202743 43 0 0 0 0 0 0 0 0 0 0 0
Totale 71.743